Middle East and Africa Urinalysis Market
No. of Pages: 136 | Report Code: TIPRE00026272 | Category: Life Sciences
No. of Pages: 136 | Report Code: TIPRE00026272 | Category: Life Sciences
MEA consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia and South Africa. The market is driven by the factors such as increasing government initiatives, growing number of kidney diseases, increasing technologies and product launches and approvals in the region.
Lockdowns imposed during the COVID-19 pandemic caused people to delay health checkups, which resulted in reduction in the number of tests performed. Also, the market suffered losses due to limited production, supply chain facilities, and business shutdown. The pandemic affected the business operations of the various key urinalysis market players. According to National Kidney Foundation, patients hospitalized for the treatment of COVID-19 are at significant risk of acute kidney injury that can cause severe illness and death. The recovered patients need to be under continuous medical observation, while the patients having blood or protein in their urine should also be monitored as they are also at a high risk of developing chronic kidney diseases. The pandemic has also impacted the regulatory environment and practices, as governments and healthcare providers face considerable challenges to meet the market demand due to increasing cases. However, the continuation of procedures can be seen as countries gradually ease their restrictions and regulatory authorities speed up approval of diagnostic products helping the market grow.
Market Overview and Dynamics
The urinalysis market in MEA is expected to grow from US$ 186.27 million in 2021 to US$ 239.74 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2021 to 2028. The demand for components required for urinalysis is rising due to the common occurrence of diabetes across the region, as the primary screening for diabetes involves urinalysis. Moreover, according to a study published by the National Kidney Foundation in 2020, ~35.0% of the diabetic population above age 20 would develop chronic kidney diseases over the period. An ongoing surge in the prevalence of prostate and bladder cancer raises a strong therapeutic imperative for the implementation of highly effective diagnostics. Thus, the escalating prevalence of UTIs, diabetes, and kidney diseases boosts MEA urinalysis market growth.
Key Market Segments
MEA urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the MEA urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The MEA urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the MEA urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The MEA urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the MEA urinalysis market is segmented into Saudi Arabia, South Africa, UAE, and rest of MEA. South Africa held the largest market share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the urinalysis market in MEA are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; and Sysmex Corporation.
Reasons to buy report
MEA
Urinalysis Market
Segmentation
MEA Urinalysis Market -
By Product
MEA Urinalysis Market - By
Test Type
MEA Urinalysis Market - By Application
MEA Urinalysis Market - By End User
MEA Urinalysis Market - By Country
MEA Urinalysis Market - Company Profiles
Strategic insights for the Middle East and Africa Urinalysis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 186.27 Million |
| Market Size by 2028 | US$ 239.74 Million |
| Global CAGR (2021 - 2028) | 3.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
The geographic scope of the Middle East and Africa Urinalysis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East and Africa Urinalysis Market is valued at US$ 186.27 Million in 2021, it is projected to reach US$ 239.74 Million by 2028.
As per our report Middle East and Africa Urinalysis Market, the market size is valued at US$ 186.27 Million in 2021, projecting it to reach US$ 239.74 Million by 2028. This translates to a CAGR of approximately 3.7% during the forecast period.
The Middle East and Africa Urinalysis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Urinalysis Market report:
The Middle East and Africa Urinalysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Urinalysis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Urinalysis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Urinalysis Market
